Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation

被引:54
作者
Cho, Youngmi [1 ]
Turner, Nancy D. [1 ]
Davidson, Laurie A. [1 ]
Chapkin, Robert S. [1 ]
Carroll, Raymond J. [2 ]
Lupton, Joanne R. [1 ]
机构
[1] Texas A&M Univ, Fac Nutr, Dept Nutr & Food Sci, College Stn, TX 77843 USA
[2] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA
关键词
docosahexaenoic acid; butyrate; apoptosis; DNA methylation; epigenetics; DNA METHYLTRANSFERASE; BLADDER-CANCER; GENES; COLONOCYTES; EXPRESSION; LINES; RAT; TUMORIGENESIS; EPIGENETICS; PROGRESSION;
D O I
10.1177/1535370213514927
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
DNA methylation and histone acetylation contribute to the transcriptional regulation of genes involved in apoptosis. We have demonstrated that docosahexaenoic acid (DHA, 22:6 n-3) and butyrate enhance colonocyte apoptosis. To determine if DHA and/ or butyrate elevate apoptosis through epigenetic mechanisms thereby restoring the transcription of apoptosis-related genes, we examined global methylation; gene-specific promoter methylation of 24 apoptosis-related genes; transcription levels of Cideb, Dapk1, and Tnfrsf25; and global histone acetylation in the HCT-116 colon cancer cell line. Cells were treated with combinations of (50 mu M) DHA or linoleic acid (18:2 n-6), (5mM) butyrate or an inhibitor of DNA methyltransferases, and 5-aza- 2'-deoxycytidine (5-Aza-dC, 2 mu M). Among highly methylated genes, the combination of DHA and butyrate significantly reduced methylation of the proapoptotic Bcl2l11, Cideb, Dapk1, Ltbr, and Tnfrsf25 genes compared to untreated control cells. DHA treatment reduced the methylation of Cideb, Dapk1, and Tnfrsf25. These data suggest that the induction of apoptosis by DHA and butyrate is mediated, in part, through changes in the methylation state of apoptosis-related genes.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 40 条
[1]  
Babidge WJ, 2001, ANTICANCER RES, V21, P2809
[2]   CpG Island Methylation Profiling in Human Salivary Gland Adenoid Cystic Carcinoma [J].
Bell, Achim ;
Bell, Diana ;
Weber, Randal S. ;
El-Naggar, Adel K. .
CANCER, 2011, 117 (13) :2898-2909
[3]  
Bender CM, 1998, CANCER RES, V58, P95
[4]   Perceptions of epigenetics [J].
Bird, Adrian .
NATURE, 2007, 447 (7143) :396-398
[5]   Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis [J].
Chang, WCL ;
Chapkin, RS ;
Lupton, JR .
CARCINOGENESIS, 1997, 18 (04) :721-730
[6]   Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function [J].
Chapkin, RS ;
Hong, MY ;
Fan, YY ;
Davidson, LA ;
Sanders, LM ;
Henderson, CE ;
Barhoumi, R ;
Burghardt, RC ;
Turner, ND ;
Lupton, JR .
LIPIDS, 2002, 37 (02) :193-199
[7]   Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis [J].
Chen, ZM ;
Guo, K ;
Toh, SY ;
Zhou, ZH ;
Li, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22619-22622
[8]   A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas [J].
Cho, Youngmi ;
Turner, Nancy D. ;
Davidson, Laurie A. ;
Chapkin, Robert S. ;
Carroll, Raymond J. ;
Lupton, Joanne R. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 237 (12) :1387-1393
[9]   A Chemoprotective Fish Oil- and Pectin-Containing Diet Temporally Alters Gene Expression Profiles in Exfoliated Rat Colonocytes throughout Oncogenesis [J].
Cho, Youngmi ;
Kim, Hyemee ;
Turner, Nancy D. ;
Mann, John C. ;
Wei, Jiawei ;
Taddeo, Stella S. ;
Davidson, Laurie A. ;
Wang, Naisyin ;
Vannucci, Marina ;
Carroll, Raymond J. ;
Chapkin, Robert S. ;
Lupton, Joanne R. .
JOURNAL OF NUTRITION, 2011, 141 (06) :1029-1035
[10]   Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis [J].
Ciavatta, Dominic J. ;
Yang, JiaJin ;
Preston, Gloria A. ;
Badhwar, Anshul K. ;
Xiao, Hong ;
Hewins, Peter ;
Nester, Carla M. ;
Pendergraft, William F., III ;
Magnuson, Terry R. ;
Jennette, J. Charles ;
Falk, Ronald J. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (09) :3209-3219